Department of Biological and Environmental Sciences and Nanoscience Center, University of Jyväskylä, Jyväskylä, Finland.
PLoS One. 2013 Jun 12;8(6):e67179. doi: 10.1371/journal.pone.0067179. Print 2013.
Human parvovirus B19 (B19V) from the erythrovirus genus is known to be a pathogenic virus in humans. Prevalence of B19V infection has been reported worldwide in all seasons, with a high incidence in the spring. B19V is responsible for erythema infectiosum (fifth disease) commonly seen in children. Its other clinical presentations include arthralgia, arthritis, transient aplastic crisis, chronic anemia, congenital anemia, and hydrops fetalis. In addition, B19V infection has been reported to trigger autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis. However, the mechanisms of B19V participation in autoimmunity are not fully understood. B19V induced chronic disease and persistent infection suggests B19V can serve as a model for viral host interactions and the role of viruses in the pathogenesis of autoimmune diseases. Here we investigate the involvement of B19V in the breakdown of immune tolerance. Previously, we demonstrated that the non-structural protein 1 (NS 1) of B19V induces apoptosis in non-permissive cells lines and that this protein can cleave host DNA as well as form NS1-DNA adducts. Here we provide evidence that through programmed cell death, apoptotic bodies (ApoBods) are generated by B19V NS1 expression in a non-permissive cell line. Characterization of purified ApoBods identified potential self-antigens within them. In particular, signature self-antigens such as Smith, ApoH, DNA, histone H4 and phosphatidylserine associated with autoimmunity were present in these ApoBods. In addition, when purified ApoBods were introduced to differentiated macrophages, recognition, engulfment and uptake occurred. This suggests that B19V can produce a source of self-antigens for immune cell processing. The results support our hypothesis that B19V NS1-DNA adducts, and nucleosomal and lysosomal antigens present in ApoBods created in non-permissive cell lines, are a source of self-antigens.
人细小病毒 B19(B19V)属于红病毒属,是一种已知的人类致病病毒。B19V 感染的流行情况已在全球范围内所有季节报告,春季发病率较高。B19V 可引起儿童常见的传染性红斑(第五病)。其其他临床表现包括关节痛、关节炎、一过性再生障碍危象、慢性贫血、先天性贫血和胎儿水肿。此外,B19V 感染已被报道可引发自身免疫性疾病,如系统性红斑狼疮和类风湿关节炎。然而,B19V 参与自身免疫的机制尚未完全阐明。B19V 引起的慢性疾病和持续感染表明,B19V 可以作为病毒与宿主相互作用以及病毒在自身免疫性疾病发病机制中的作用的模型。在这里,我们研究了 B19V 参与免疫耐受破坏的情况。以前,我们证明 B19V 的非结构蛋白 1(NS1)可诱导非允许细胞系中的细胞凋亡,并且该蛋白可切割宿主 DNA 并形成 NS1-DNA 加合物。在这里,我们提供的证据表明,通过程序性细胞死亡,非允许细胞系中 B19V NS1 表达可产生凋亡小体(ApoBods)。对纯化的 ApoBods 的特征分析确定了其中的潜在自身抗原。特别是,与自身免疫相关的标志性自身抗原,如 Smith、ApoH、DNA、组蛋白 H4 和磷脂酰丝氨酸,存在于这些 ApoBods 中。此外,当纯化的 ApoBods 被引入分化的巨噬细胞中时,会发生识别、吞噬和摄取。这表明 B19V 可以产生免疫细胞处理的自身抗原来源。这些结果支持我们的假设,即 B19V NS1-DNA 加合物以及非允许细胞系中产生的 ApoBods 中的核小体和溶酶体抗原,是自身抗原的来源。